Psyence Group Inc.
CNQ: PSYG.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Jody Aufrichtig
- Headquarters
- Toronto, Canada
- IPO year
- 2021
- Market cap
- CA$1.9M
- Website
- https://www.psyence.com
Loading PSYG…
Loading profile data…Frequently asked questions about PSYG
What does Psyence Group Inc. (PSYG.CN) do?
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal...
Where does PSYG.CN trade?
Psyence Group Inc. (PSYG.CN) trades on the Canadian Securities Exchange.
What sector is PSYG.CN in?
Psyence Group Inc. (PSYG.CN) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Psyence Group Inc.?
Jody Aufrichtig is the chief executive officer of Psyence Group Inc. (PSYG.CN).
Where is Psyence Group Inc. headquartered?
Psyence Group Inc. is headquartered in Canada.
Does PSYG.CN pay a dividend?
Psyence Group Inc. (PSYG.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PSYG.CN go public?
Psyence Group Inc. (PSYG.CN) completed its initial public offering in 2021.